Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS13: Age specific care: Adolescents and young adults (AYA)

CN24 - Sexual function in young adults following a brain tumour diagnosis


21 Sep 2020


EONS13: Age specific care: Adolescents and young adults (AYA)


Charlotta Bergstrom


Annals of Oncology (2020) 31 (suppl_4): S1075-S1075. 10.1016/annonc/annonc316


C.M. Bergstrom1, L.E. Eriksson2, C. Hedman3, C. Lampic1, L. Wettergren1

Author affiliations

  • 1 Department Of Women's And Children's Health, Karolinska Institutet, SE-17177 - Stockholm/SE
  • 2 Department Of Learning Informatics, Management And Ethics, Karolinska Institutet, 171 77 - Stockholm/SE
  • 3 Department Of Molecular Medicine And Surgery, Karolinska Institutet, 171 77 - Stockholm/SE


Login to access the resources on OncologyPRO.

Abstract CN24


Young adults (YAs) treated for cancer commonly report a negative impact on sexual life. However, the situation for YAs with brain tumors is largely unknown. The aim of this study was therefore to compare sexual dysfunction in YAs with brain tumors to those with other types of tumors. Furthermore, to investigate to what extent the YAs with brain tumors had discussed sexual issues with a health care professional.


The Fex-Can study is a population-based study investigating sexual function and fertility-related distress in YAs diagnosed with cancer in Sweden. All patients diagnosed with selected cancers (breast, testicular, cervix, ovarian, lymphoma) or brain tumors at age 18-39 years were identified via National Cancer Quality Registers and approached with a survey approximately 1.5 years after diagnosis. Sexual function was measured with the PROMIS SexFS. To compare proportions between groups, the χ2-test or Fisher's Exact test were used.


A total of 1010 participants (response rate 67%), 123 with brain tumors and 887 with other cancers participated. 41% of the men and 56% of the women with brain tumors reported at least one sexual dysfunction with most problems related to satisfaction with sex life, sexual interest and orgasm ability (only women). Overall, few differences were seen between YAs with brain tumors and YAs with other cancers, regardless of sex. Men with brain tumors reported lower sexual interest (30%) than men with other cancers (12%, p<0.01), whereas women reported less problem with vaginal lubrication (6%) compared to women with other cancers (22%, p<0.01). A majority (68%) of YAs with brain tumors did not recall any discussions of possible impact of the cancer on sex life with a health care professional compared to YAs with other cancers (21%, p<0.001).


Overall, few differences in sexual dysfunction were detected between YAs with brain tumors and other cancers, yet only 20% of the YAs with brain tumors remembered having talked to a caregiver about potential impact on their sex life. There is a need to routinely address sexual issues in clinical care.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Claudia Lampic and Lena Wettergren.


The Cancer Research Foundations of Radiumhemmet (grant number 161272); the Swedish Cancer Society (CAN 2013/886 and CAN 2016/615); the Swedish Childhood Cancer Foundation (TJ2014-0050); the Vårdal Foundation (2014-0098); the Swedish Research Council for Health, Working Life and Welfare (2014-4689); the Swedish Research Council (2017-01530).


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings